ICAM1 and central nervous system cancer: We confirmed this result using GSC17 glioma stem cells (as GSC17 cells have a lower baseline ICAM1 expression level) and found that the ICAM-1 expression level was also increased under hypoxic conditions or after CoCl2 treatment in these cells (Supplementary Figure 2).